Alkem Laboratories Ltd Share Price

5,193.15
(0.24%)
Jul 24, 2024|03:32:55 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open5,207.9
  • Day's High5,271.75
  • 52 Wk High5,578.8
  • Prev. Close5,180.65
  • Day's Low5,160.65
  • 52 Wk Low3,447
  • Turnover (lac)5,836.06
  • P/E34.38
  • Face Value2
  • Book Value928.11
  • EPS150.52
  • Mkt. Cap (Cr.)62,091.9
  • Div. Yield0.77
Loading...
  • Open5,202.25
  • Day's High5,274
  • Spot5,185.75
  • Prev. Close5,184.3
  • Day's Low5,156.5
  • ViewLong BuildUp
  • Market Lot100
  • OI(Chg %)64,000 (11.85%)
  • Roll Over%0.41
  • Roll Cost1.02
  • Traded Vol.5,91,500 (13.31%)
View More Futures

Alkem Laboratories Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

5,207.9

Prev. Close

5,180.65

Turnover(Lac.)

5,836.06

Day's High

5,271.75

Day's Low

5,160.65

52 Week's High

5,578.8

52 Week's Low

3,447

Book Value

928.11

Face Value

2

Mkt Cap (₹ Cr.)

62,091.9

P/E

34.38

EPS

150.52

Divi. Yield

0.77

Alkem Laboratories Ltd Corporate Action

9 Feb 2024

12:00 AM

Dividend

Dividend Amount: 35

Record Date: 17 Feb, 2024

arrow

16 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

19 May 2023

12:00 AM

AGM

Announcement Date: 19 May, 2023

arrow

Alkem Laboratories Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Alkem Laboratories Ltd SHAREHOLDING SNAPSHOT

24 Jul, 2024|06:54 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 56.37%

Foreign: 0.00%

Indian: 56.37%

Non-Promoter- 27.26%

Institutions: 27.26%

Non-Institutions: 16.35%

Custodian: 0.00%

Share Price

Alkem Laboratories Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

23.91

23.91

23.91

23.91

Preference Capital

0

0

0

0

Reserves

9,325.94

8,719.75

7,601.84

6,256.53

Net Worth

9,349.85

8,743.66

7,625.75

6,280.44

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

8,829.81

7,219.68

6,677.08

5,300.26

yoy growth (%)

22.3

8.12

25.97

16.53

Raw materials

-3,565.89

-2,665.02

-2,550.56

-2,075.22

As % of sales

40.38

36.91

38.19

39.15

Employee costs

-1,434.49

-1,158.72

-1,066.76

-861.63

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

1,753.37

1,897.08

1,338.08

934.29

Depreciation

-218.98

-198.93

-186.84

-107.65

Tax paid

-212.12

-199.22

-73.66

-218.45

Working capital

954.38

1,212.29

1,245.84

514.21

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

22.3

8.12

25.97

16.53

Op profit growth

-7.11

32.79

47.85

13.05

EBIT growth

-7.66

40.9

42.42

5.28

Net profit growth

-8.53

33.26

76.63

-18.94

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

12,667.58

11,599.26

10,634.19

8,865.01

8,344.36

Excise Duty

0

0

0

0

0

Net Sales

12,667.58

11,599.26

10,634.19

8,865.01

8,344.36

Other Operating Income

0

0

0

0

0

Other Income

310.84

216.08

162.65

233.21

104.22

Alkem Laboratories Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,601.6

125.973,84,469.44867.60.845,536.9998.75

Cipla Ltd

CIPLA

1,497.9

32.551,20,921.781,038.40.573,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,527

76.161,19,967.915310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,148.85

33.631,15,601.191,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,865

26.731,14,525.251,034.80.585,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Alkem Laboratories Ltd

Management

Register Office

Registrar Office

Executive Chairman

Basudeo N Singh

Managing Director

SANDEEP SINGH

Executive Director

Mritunjay Kumar Singh

Non-Exec. & Independent Dir.

A K Purwar

Non-Exec. & Independent Dir.

SANGEETA KAPILJIT SINGH

Non-Exec. & Independent Dir.

SUDHA RAVI

Company Sec. & Compli. Officer

Manish Narang

Non-Exec. & Independent Dir.

Dheeraj Sharma

Non-Exec. & Independent Dir.

Narendra Aneja

Executive Director

SARVESH SINGH

Executive Director

Madhurima Singh

Independent Director

Sujjain Talwar

Executive Director

Srinivas Singh

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. With a portfolio of more than 800 brands in India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales. The company also has presence in more than 40 international markets, with the United States being its key focus market. Alkem Laboratories Ltd was incorporated as a private limited company on August 8, 1973 at Patna under the Companies Act, 1956 and subsequently became a deemed public limited company under section 43A(2) of Companies Act, 1956 on October 26, 1988. Pursuant to Company passing a resolution under section 21 of Companies Act, 1956 and upon issuance of a fresh certificate of incorporation consequent on change of name dated August 21, 2001, the name of Company was changed to Alkem Laboratories Limited with effect from October 26, 1988.In 1978, the company established its first plant at Taloja Maharashtra. In 1992, the company established its manufacturing facility in Mandwa, Maharashtra, which was later converted into an API facility in 2005. In 2003, the company set up a research and development facility for ANDA development
Read More

Company FAQs

What is the Alkem Laboratories Ltd share price today?

Down Arrow

The Alkem Laboratories Ltd shares price on N/A is Rs.₹5190.55 today.

What is the Market Cap of Alkem Laboratories Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Alkem Laboratories Ltd is ₹62060.81 Cr. as of 24 Jul ‘24

What is the PE and PB ratio of Alkem Laboratories Ltd?

Down Arrow

The PE and PB ratios of Alkem Laboratories Ltd is 34.38 and 5.86 as of 24 Jul ‘24

What is the 52 Week High and Low of Alkem Laboratories Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Alkem Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Alkem Laboratories Ltd is ₹3440.05 and ₹5581.2 as of 24 Jul ‘24

What is the CAGR of Alkem Laboratories Ltd?

Down Arrow

Alkem Laboratories Ltd's CAGR for 5 Years at 24.07%, 3 Years at 15.10%, 1 Year at 36.90%, 6 Month at 7.35%, 3 Month at 10.08% and 1 Month at 3.26%.

What is the shareholding pattern of Alkem Laboratories Ltd?

Down Arrow

The shareholding pattern of Alkem Laboratories Ltd is as follows:
Promoters - 56.38 %
Institutions - 27.27 %
Public - 16.36 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.